Near infrared and Raman spectroscopy as Process Analytical Technology tools for the manufacturing of silicone-based drug reservoirs

Analytica Chimica Acta

Volumn 699, Issue 1, 2011, Pages 96-106

  Mantanus, J ^a   Rozet, E ^a   Van Butsele, K ^b   De Bleye, C ^a   Ceccato, A ^b   Evrard, B ^a   Hubert, Ph ^a   Ziemons E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Odyssea pharma ^*  (Belgium)

Author keywords

Chemometrics; Process Analytical Technology; Quality by Design; Silicone based drug reservoirs; Validation; Vibrational spectroscopy

Indexed keywords

CHEMOMETRICS; PROCESS ANALYTICAL TECHNOLOGY; QUALITY BY DESIGN; SILICONE-BASED DRUG RESERVOIRS; VALIDATION;

INFRARED DEVICES; MANUFACTURE; MATHEMATICAL MODELS; NEAR INFRARED SPECTROSCOPY; RAMAN SCATTERING; RAMAN SPECTROSCOPY; SILICONES;

PRINCIPAL COMPONENT ANALYSIS;

ACTIVE PHARMACEUTICAL INGREDIENT; DIMETICONE; DRUG; SILICONE; UNCLASSIFIED DRUG;

ACCURACY; ANALYTICAL ERROR; ARTICLE; CALIBRATION; CHEMOMETRICS; CONTROLLED STUDY; CROSS LINKING; DRUG DETERMINATION; DRUG IMPLANT; DRUG MANUFACTURE; DRUG MIXTURE; HEATING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NEAR INFRARED SPECTROSCOPY; PREDICTION; PRIORITY JOURNAL; RAMAN SPECTROMETRY; TEMPERATURE SENSITIVITY; VALIDATION PROCESS;

CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; LEAST-SQUARES ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; SILICONES; SPECTROSCOPY, NEAR-INFRARED; SPECTRUM ANALYSIS, RAMAN;

EID: 79959491592     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2011.05.006     Document Type: Article

References (44)

1. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q8(R2) 2009, Pharmaceutical Development, Geneva.
2. Tabasi S.H., Fahmy R., Bensley D., O'brien C., Hoag S.W. J. Pharm. Sci. 2008, 97:4040-4051.
3. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q10 2008, Pharmaceutical Quality System, Geneva.
4. Kunzler J.F. Trends Polym. Sci. 1996, 4:52-59.
5. Chen Z., Ward R., Tian Y., Malizia F., Gracias D.H., Shen Y.R. J. Biomed. Mater. Res. 2002, 62:254-264.
6. Abbasi F., Mirzadeh H., Katbab A.-A. Polym. Int. 2001, 50:1279-1287.
7. United States Food and Drug Administration (FDA) Guidance for Industry PAT-A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance 2004, FDA.
8. Li X. Design of Controlled Release Drug Delivery Systems 2005, McGraw-Hill Professional, New York. first ed.
9. United States Food and Drug Administration (FDA) Pharmaceutical CGMPs for the 21st Century - A Risk-based Approach 2004, FDA.
10. Burns D.A., Ciurczak E.W. Handbook of Near-Infrared Analysis 2008, CRC Press, New York. third ed.
11. Luypaert J., Massart D.L., Vander Heyden Y. Talanta 2007, 72:865-883.
12. Sasic S. Pharmaceutical Applications of Raman Spectroscopy 2007, John Wiley & Sons, New Jersey.
13. Balabin R.M., Safieva R.Z., Lomakina E.I. Anal. Chim. Acta 2010, 671:27-35.
14. Flumignan D.L., Tininis A.G., de Oliveira Ferreira F., de Oliveira J.E. Anal. Chim. Acta 2007, 595:128-135.
15. Müller J., Knop K., Thies J., Uerpmann C., Kleinebudde P. Drug Dev. Ind. Pharm. 2010, 36:234-243.
16. De Beer T.R.M., Bodson C., Dejaegher B., Walczak B., Vercruysse P., Burggraeve A., Lemos A., Dellatre L., Vander Heyden Y., Remon J.P., Vervaet C., Baeyens W.R.G. J. Pharm. Biomed. Anal. 2008, 48:772-779.
17. De Beer T.R.M., Wiggenhorn M., Veillon R., Debacq C., Mayeresse Y., Moreau B., Burggraeve A., Quinten T., Friess W., Winter G., Vervaet C., Remon J.P., Baeyens W.R.G. Anal. Chem. 2009, 81:7639-7649.
18. Bodson C., Rozet E., Ziemons E., Evrard B., Hubert Ph., Delattre L. J. Pharm. Biomed. Anal. 2007, 45:356-361. http://hdl.handle.net/2268/1642.
19. Moes J.J., Ruijken M.M., Gout E., Frijlink H.W., Ugwoke M.I. Int. J. Pharm. 2008, 357:108-118.
20. Skibsted E.T.S., Westerhuis J.A., Smilde A.K., Witte D.T. J. Pharm. Biomed. Anal. 2007, 43:1297-1305.
21. Li W., Bagnol L., Berman M., Chiarella R.A., Gerber M. Int. J. Pharm. 2009, 380:49-54.
22. Grohganz H., Gildemyn D., Skibsted E., Flink J.M., Rantanen J. Anal. Chim. Acta 2010, 676:34-40.
23. Rosa S.S., Barata P.A., Martins J.M., Menezes J.C. Talanta 2008, 75:725-733.
24. Mantanus J., Ziémons E., Lebrun P., Rozet E., Klinkenberg R., Streel B., Evrard B., Hubert Ph. Anal. Chim. Acta 2009, 642:186-192. http://hdl.handle.net/2268/18780.
25. Mantanus J., Ziémons E., Rozet E., Streel B., Klinkenberg R., Evrard B., Rantanen J., Hubert Ph. Talanta 2010, 83:305-311. http://hdl.handle.net/2268/69980.
26. Rantanen J., Lehtola S., Rämet P., Mannermaa J.P., Yliruusi J. Powder Technol. 1998, 99:163-170.
27. Rantanen J., Räsänen E., Antikainen O., Mannermaa J.P., Yliruusi J. Chemom. Intell. Lab. Syst. 2001, 56:51-58.
28. Sandler N., Rantanen J., Heinämäki J., Römer M., Marvola M., Yliruusi J. AAPS PharmSciTech 2005, 6(2):174-183.
29. Tabasi S.H., Moolchandani V., Fahmy R., Hoag S.W. Int. J. Pharm. 2009, 382:1-6.
30. Maurer L., Leuenberger H. Int. J. Pharm. 2009, 370:8-16.
31. Ravn C., Skibsted E., Bro R. J. Pharm. Biomed. Anal. 2008, 48:554-561.
32. Blanco M., Alcalá M. Anal. Chim. Acta 2006, 557:353-359.
33. Blanco M., Alcalá M., Bautista M. Eur. J. Pharm. Sci. 2008, 33:409-414.
34. Saerens L., Dierickx L., Lenain B., Vervaet C., Remon J.P., De Beer T. Eur. J. Pharm. Biopharm. 2011, 77:158-163.
35. Martens H., Naes T. Multivariate Calibration 1996, John Wiley & Sons, Chichester.
36. Wold S., Sjöström M., Eriksson L. Chemom. Intell. Lab. Syst. 2001, 58:109-130.
37. (accessed 11.01.11). http://wiki.eigenvector.com/index.php?title=Using_Cross-Validation.
38. International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q2 (R1) 2005, Validation of Analytical Procedures: Text and Methodology, Geneva.
39. Hubert Ph., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L. J. Pharm. Biomed. Anal. 2004, 36:579-586. http://hdl.handle.net/2268/6169.
40. Analytical Methods Committee Analyst 1995, 120:2303-2308.
41. Eurachem/Citac Guide, Quantifying the Uncertainty in Analytical Measurement 2000, second ed.
42. CB EA-4/16 EA Guidelines on the Expression of Uncertainty in Quantitative Testing 2004, http://www.european-accreditation.org/.
43. Feinberg M., Boulanger B., Dewé W., Hubert Ph. Anal. Bioanal. Chem. 2004, 380:502-514. http://hdl.handle.net/2268/6186.
44. Rozet R., Dewe W., Rudaz S., Marini Djang'Eing'A R., Ziemons E., Boulanger B., Hubert Ph. Trends Analyt. Chem. 2011, 30:797-806.